Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year total asset growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -9.45% |
| Q3 2025 | -5.12% |
| Q2 2025 | -5.65% |
| Q1 2025 | -3.45% |
| Q4 2024 | -12.80% |
| Q3 2024 | 1.36% |
| Q2 2024 | 38.68% |
| Q1 2024 | 184.28% |
| Q4 2023 | -11.43% |
| Q3 2023 | -8.01% |
| Q2 2023 | -5.88% |
| Q1 2023 | 119.03% |
| Q4 2022 | -6.81% |
| Q3 2022 | -2.95% |
| Q2 2022 | -2.53% |
| Q1 2022 | -1.69% |
| Q4 2021 | -2.12% |
| Q3 2021 | -2.42% |
| Q2 2021 | -1.21% |
| Q1 2021 | 359.49% |
| Q4 2020 | 93.31% |
| Q3 2020 | -7.75% |
| Q2 2020 | -2.93% |
| Q1 2020 | 0.32% |
| Q4 2019 | -11.76% |
| Q3 2019 | 7.45% |
| Q2 2019 | -10.94% |
| Q1 2019 | -11.18% |
| Q4 2018 | -10.74% |
| Q3 2018 | 78.99% |
| Q2 2018 | -10.42% |
| Q1 2018 | -11.26% |
| Q4 2017 | -13.01% |
| Q3 2017 | -12.13% |
| Q2 2017 | -11.99% |
| Q1 2017 | -6.97% |
| Q4 2016 | -10.19% |
| Q3 2016 | -7.83% |
| Q2 2016 | -8.56% |
| Q1 2016 | -4.57% |